Latest Microalbuminuria Stories
In a large national study, higher levels of the urinary albumin-to-creatinine ratio was associated with greater risk of incident but not recurrent coronary heart disease in black individuals when compared with white individuals.
A review of data from seven clinical trials suggests that intensive glucose control is associated with reduced risk of microalbuminuria and macroalbuminuria (conditions characterized by excessive levels of protein in the urine usually resulting from damage to the filtering units of the kidneys).
Combining the chronic kidney disease markers of creatinine-based estimated glomerular filtration rate and urine albumin-to-creatinine ratio with the biomarker cystatin C was associated with improved prediction of end-stage kidney disease and all-cause death.
A morning urine test is superior to all other tests for detecting declining kidney performance in patients with diabetic kidney disease.
Simple urine test may help identify patients at risk.
Dutch researchers have linked elevated levels of the protein albumin in urine to increased blood clot risk. The eight-year study, published in the Journal of the American Medical Association, found 3 percent of study participants with microalbuminuria -- having albumin in urine of 30-300 mg per 24-hour urine collection -- developed a condition in which a blood clot or thrombus forms in a vein, or venous thromboembolism.
Preliminary research suggests that higher than normal levels of the protein albumin in urine is associated with an increased risk for blood clots in the deep veins of the legs or lungs (venous thromboembolism; VTE), according to a study in the May 6 issue of JAMA.
Women who drink two or more cans of soda pop per day are nearly twice as likely to show early signs of kidney disease, a U.S. study said.
Researchers in Britain and Pakistan say high doses of thiamine, or vitamin B1, can reverse the onset of early diabetic kidney disease. Dr. Naila Rabbani and Paul J.
HemoCue, a wholly owned subsidiary of Quest Diagnostics, has announced that its HemoCue Albumin 201 System is the first quantitative point-of-care test for screening, diagnosing and monitoring microalbuminuria to be granted a CLIA waiver by the FDA.
- A political dynamiter.